Have a personal or library account? Click to login
Synthesis and characterization of some novel 1,2,4-triazoles, 1,3,4-thiadiazoles and Schiff bases incorporating imidazole moiety as potential antimicrobial agents Cover

Synthesis and characterization of some novel 1,2,4-triazoles, 1,3,4-thiadiazoles and Schiff bases incorporating imidazole moiety as potential antimicrobial agents

Open Access
|May 2015

References

  1. 1. E. D. Weinber, Antifungal Agents. Burger’s Medicinal Chemistry and Drug Discovery, 5th ed., Wiley Interscience, New York 1996, Vol. 2, pp. 637-652.
  2. 2. U. Sahoo, S. Biswal, S. Sethy, H. K. S. Kumar and M. Banerjee, Imidazole and its biological activities: A review, Asian J. Res. Chem. 5 (2012) 171-182.
  3. 3. M. Mahdavi, T. Akbarzadeh, V. Sheibani, M. Abbasi, L. Firoozpour, S. A. Tabatabaic, A. Shafiee and A. Foroumadi, Synthesis of two novel 3- amino- 5- [4- chloro- 2- phenoxyphenyl] - 4H- 1, 2, 4- triazoles with anticonvulsant activity, Iranian J. Pharm. Res. 9 (2010) 265-269.
  4. 4. O. Bekircan, B. Kahveci and O. B. Ozgumus, Synthesis of some N- alkoxycarbonyl- N’’- benzoylbenzamidrazones( p- toluamidrazones) and 1, 3, 5- trisubstituted 1, 2, 4- triazole derivatives from Nbenzoylimidates and their antimicrobial and anticancer screening studies, Chin. J. Chem. 25 (2007) 1871-1877; DOI: 10.1002/cjoc.200790345.10.1002/cjoc.200790345
  5. 5. M. Hamdy, A. Rahman and M. Hussein, Synthesis of b-hydroxypropanoic acid derivatives as anti-inflammatory, analgesic and antimicrobial agents, Arch. Pharm. Chem. Life Sci. 339 (2006) 378-387; DOI: 10.1002/ardp.200600016.10.1002/ardp.200600016
  6. 6. O. Bekircan, M. Kucuk, B. Kahveci and S. Kolaylı, Convenient synthesis of fused heterocyclic 1, 3, 5- triazines from some N- acyl imidates and heterocyclic amines as anticancer and antioxidant agents, Arch. Pharm. 338 (2005) 365-372; DOI: 10.1002/ardp.200400964.10.1002/ardp.200400964
  7. 7. G. T. Zitouni, Z. A. Kaplancıklı, A. Ozdemir, P. Chevallet, H. B. Kandilci and B. Gumus, Studies on 1,2,4-triazole derivatives as potential anti-inflammatory agents, Arch. Pharm. Chem. Life Sci. 340 (2007) 586-590; DOI: 10.1002/ardp.200700134.10.1002/ardp.200700134
  8. 8. B. Chai, X. Qian, S. Cao, H. Liu and G. Song, Synthesis and insecticidal activity of 1,2,4-triazole derivatives, ARKIVOC ii (2003) 141-145.10.3998/ark.5550190.0004.216
  9. 9. M. M. Ghorab, S. G. Abdel-Hamide, G. M. Ali and E. H. Shaurub, Synthesis and insecticidal activity of some new 3- [4(3H) - quinazolinone- 2- yl) thiomethyl] - 1, 2, 4- triazole- 5- thiols, Pestic. Sci. 48 (1996) 31-35; DOI: 10.1002/(SICI)1096-9063(199609)48.
  10. 10. G. Turan-Zitouni, Z. A. Kaplancıklı and A. Ozdemir, Synthesis of some triazolylthioacetamidobenzofuran derivatives, Farmaco 57 (2002) 573-578; DOI: 10.1016/S0014-827X(02)01250-8.10.1016/S0014-827X(02)01250-8
  11. 11. M. Chen, X.-F. Wang, S.-S. Wang, Y.-X. Feng, F. Chen and C.-L. Yang, Synthesis, characterization and fungicidal activities of novel fluorinated 3,5-disubstituted-4H-1,2,4-triazol-4-amines, J. Fluorine Chem. 135 (2012) 324 323-329; DOI: 10.1016/j.jfluchem.2011.12.015.10.1016/j.jfluchem.2011.12.015
  12. 12. A. Foroumadi, S. Emami, A. Hassanzadeh, M. Rajaee, K. Sokhanvar, M. H. Moshafiand A. Shafiee, Synthesis and antibacterial activity of N- (5- benzylthio- 1, 3, 4- thiadiazol- 2- yl) and N- (5- benzylsulfonyl-1, 3, 4- thiadiazol- 2- yl) piperazinyl quinolone derivatives, Bioorg. Med. Chem. Lett. 15 (2005) 4488-4492; DOI: 10.1016/j.bmcl.2005.07.016.10.1016/j.bmcl.2005.07.01616105736
  13. 13. B. Modzelewska-Banachiewicz, J. Banachiewicz, A. Chodkowska, E. Jagiello-Wojtowicz and L. Mazur, Synthesis and biological activity of new derivatives of 3- (3, 4- diaryl- 1, 2, 4- triazole- 5- yl) propenoic acid, Eur. J. Med. Chem. 39 (2004) 873-877; DOI: 10.1016/j.ejmech.2004.07.002.10.1016/j.ejmech.2004.07.00215464621
  14. 14. N. Solak and S. Rollas, Synthesis and antituberculosis activity of 2- (aryl /alkylamino) - 5- (4- aminophenyl) - 1, 3, 4- thiadiazoles and their Schiff bases, ARKIVOC xii (2006) 173-181; DOI: 10.3998/ ark.5550190.0007.c20.
  15. 15. S. Schenone, C. Brullo, O. Bruno, F. Bondavalli, A. Ranise, W. Filippelli, B. Rinaldi, A. Capuano and G. Falcone, New 1, 3, 4- thiadiazole derivatives endowed with analgesic and anti- inflammatory activities, Bioorg. Med. Chem. 14 (2006) 1698-1705; DOI: 10.1016/j.bmc.2005.10.064.10.1016/j.bmc.2005.10.06416310359
  16. 16. S. Rollas, N. Gulerman and H. Erdeniz, Synthesis and antimicrobial activity of some new hydrazones of 4- fluorobenzoic acid hydrazide and 3- acetyl- 2, 5- disubstituted- 1, 3, 4- oxadiazolines, Farmaco 57 (2002) 171-174; DOI: 10.1016/S0014-827X(01)01192-2.10.1016/S0014-827X(01)01192-2
  17. 17. T. R. Bal, B. Anand, P. Yogeeswari and D. Sriram, Synthesis and evaluation of anti- HIV activity of isatin b- thiosemicarbazone derivatives, Bioorg. Med. Chem. Lett. 15 (2005) 4451-4455; DOI: 10.1016/j. bmcl.2005.07.046.
  18. 18. S. N. Pandeya, D. Sriram, G. Nath and E. De Clercq, Synthesis, antibacterial, antifungal and anti- HIV activities of Schiff and Mannich bases derived from isatin derivatives and N- [4- (4’- chlorophenyl) thiazol- 2- yl] thiosemicarbazide, Eur. J. Pharm. Sci. 9 (1999) 25-31; DOI: 10.1016/S0928-0987(99)00038-X.10.1016/S0928-0987(99)00038-X
  19. 19. S. N. Pandeya, D. Sriram, G. Nath and E. De Clercq, Synthesis, antibacterial, antifungal and anti- HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole, Arzneim. Forsch. 50 (2000) 55-59.
  20. 20. S. M. Sondhi, M. Dinodia and A. Kumar, Synthesis, anti- inflammatory and analgesic activity evaluation of some amidine and hydrazone derivatives, Bioorg. Med. Chem. 14 (2006) 4657-4663; DOI: 10.1016/j.bmc.2006.02.014.10.1016/j.bmc.2006.02.014
  21. 21. M. R. Maurya, S. Agarwal, M. Abid, A. Azam, C. Bader, M. Ebel and D. Rehder, Synthesis, characterization, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV) , oxovanadium(V) and m- bis(oxo) bis{oxovanadium(V) } complexes, Dalton Trans. (2006) 937-947; DOI: 10.1039/B512326G.10.1039/B512326G
  22. 22. E. S. H. El Ashry, A. A. Kassem, H. Abdel-Hamid, F. F. Louis, Sh. A. N. Khattab and M. R. Aouad, Synthesis of 4- amino- 5- (3- chloro- 2- benzothienyl) - 3- mercapto- 1, 2, 4- triazolo[3, 4- b][1, 3, 4] thiadiazoles and triazolo[3, 4, b] [1, 3, 4] thiadiazines under classical and microwave conditions, ARKIVOC xiv (2006) 119-132.10.3998/ark.5550190.0007.e14
  23. 23. A. H. K. Sharba, R. H. Al-Bayati, N. Rezki and M. R. Aouad, Synthesis of thiadiazoles and 1, 2, 4- triazoles derived from cyclopropane dicarboxylic acid, Molecules 10 (2005) 1153-1160; DOI: 10.3390/10091153.10.3390/10091153
  24. 24. M. R. Aouad, N. Rezki, M. Kasmi, L. Aouad and M. A. Rezki, Synthesis, characterization and evaluation of antimicrobial activity of some novel 1, 2, 4- triazoles and 1, 3, 4- thiadiazoles bearing imidazole nucleus, Heterocycles 85 (2012) 1141-1154; DOI: 10.3987/COM-12-12456.10.3987/COM-12-12456
  25. 25. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Determination of Minimum Inhibitory Concentrations (MICs) of Antibacterial Agents by Agar Dilution, Clin. Microbiol. Infect. (Suppl. 6) (2000) 509-515; DOI: 10.1046/j.1469-0692.2000.00142.x.
  26. 26. National Committee for Clinical Laboratory Standards, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A5, 5th ed., NCCLS, Wayne 2000.
  27. 27. E. S. H. El Ashry, N. Rashed, L. F. Awad, E. Ramadan, S. M. Abdel-Maggeed and N. Rezki, MAOS versus conventional synthesis of 4, 5- di- and 3, 4, 5- triphenylimidazole- 2- thione and their derivatives, ARKIVOC vii (2007) 30-40.10.3998/ark.5550190.0008.705
  28. 28. H. Kumar, S. A. Javed, S. A. Khan and M. Amir, 1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: synthesis and preliminary evaluation of biological properties, Eur. J. Med. Chem. 43 (2008) 2688-2698; DOI: 10.1016/j.ejmech.2008.01.039.10.1016/j.ejmech.2008.01.039
  29. 29. N. Galic, B. Peric, B. Kojic-Prodic and Z. Cimerman, Structural and spectroscopic characteristics of aroylhydrazones derived from nicotinic acid hydrazide, J. Mol. Struct. 559 (2001) 187-194; DOI: 10.10.1016/S0022-2860(00)00703-1.10.1016/S0022-2860(00)00703-1
  30. 30. V. Klimesova, L. Zahajska, K. Waisser, J. Kaustova and U. Mollmann, Synthesis and antimycobacterial activity of 1, 2, 4- triazole 3- benzylsulfanyl derivatives, Farmaco 59 (2004) 279-288; DOI: 10.1016/j.farmac.2004.01.006.10.1016/j.farmac.2004.01.00615081345
DOI: https://doi.org/10.1515/acph-2015-0011 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 117 - 132
Accepted on: Oct 27, 2014
Published on: May 23, 2015
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2015 Mohamed Reda Aouad, Mouslim Messali, Nadjet Rezki, Adeeb Al-Sheikh Ali, Alain Lesimple, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.